Showing 36-40 of 60 :
Data Book podcast: Joe Zabinski of OM1 talks about AI and ChatGPT

Chief Healthcare Executive Apr 17, 2023 Ron Southwick Listen to the full podcast >> Artificial intelligence is being touted as having the potential to revolutionize healthcare. Joe Zabinski says that the future may not be too far away. “In terms of how close we are to this having widespread adoption, I think we’re closer than[…]

OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine

April 13, 2023 BusinessWire Read the full release >> The digital phenotyping platform, PhenOM, is delivering personalized and actionable healthcare insights around diagnosis, treatment, risk, utilization, and clinical trials BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligence-powered platform for personalized medicine. Calibrated[…]

Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of Care

American Journal of Managed Care Mar 17, 2023 Christina Mattina Read the Full Article >> Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to[…]

AI Uncovers Other Patients Like You to Support Doctors with ChatGPT

Watch the full interview from Healthcare IT about ChatGPT for un-diagnosed patients with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1. The road to diagnosis can be taxing for patients and once diagnosed, personalized treatment plans are still created with an element of guess work. Automation and artificial intelligence (AI) are the[…]

1 6 7 8 9 10 12